 | • レポートコード：QYR9ST00878 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、110ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界のデング熱ワクチン市場について調査・分析し、以下の構成でお届け致します。デング熱ワクチンの種類別には、CYD-TDV、DENVaxまたはTAK-003、TetraVax-DV、TDENV PIV、V180、DNAワクチンに、用途別には、政府機関、病院、NGOに、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別デング熱ワクチン売上データ ・地域別デング熱ワクチン市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別デング熱ワクチン市場規模：CYD-TDV、DENVaxまたはTAK-003、TetraVax-DV、TDENV PIV、V180、DNAワクチン ・用途別デング熱ワクチン市場規模：政府機関、病院、NGO ・主要メーカーの企業情報：GlaxoSmithKline、Merck Sharp & Dohme、Sanofi、Takeda Pharmaceuticals、GeneOne Life Sciences、Medigen Biologics、Panacea Biotec、Sun Pharmaceutical、U.S NIH、Vabiotec ・デング熱ワクチンの市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking.With the increasing population density and global warming, there is a rapid growth in the prevalence of dengue, especially in the tropical and subtropical regions across the world. According to the National Institute of Health, approximately 0.05 to 0.2 billion cases of dengue infections are reported annually and the mortality rate due to dengue was above 20,000. The report has identified the rapid growth in disease incidences as one of the primary factors that will fuel the growth of the dengue vaccine market in the coming years. The prevalence of dengue is present in more than 125 countries across the world and the rising prevalence of dengue will drive the market during the forecast period.
The dengue vaccine market is marginally concentrated due to the presence and dominance of the established players. Several companies are investing in R&D to develop more advanced products and expand their product portfolio. Several organizations are merging for research and making enormous efforts to develop vaccines that can challenge the Sanofi Pasteur’s exclusivity in the dengue treatment market. Moreover, several organizations are making huge investments in R&D to develop novel treatment options.
The Americas will be the major revenue contributor to the dengue vaccine market owing to the increasing incidences of dengue cases. The dengue treatment market in the Americas will profit from the bilateral program, Indo-U.S. Vaccine Action Program (VAP), which is concentrated on activities related to immunization and vaccine-related research.
The global Dengue Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dengue Vaccine market based on company, product type, end user and key regions.
This report studies the global market size of Dengue Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dengue Vaccine in these regions.
This research report categorizes the global Dengue Vaccine market by top players/brands, region, type and end user. This report also studies the global Dengue Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
GlaxoSmithKline
Merck Sharp & Dohme
Sanofi
Takeda Pharmaceuticals
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical
U.S NIH
Vabiotec
Market size by Product
CYD-TDV
DENVax or TAK-003
TetraVax-DV
TDENV PIV
V180
DNA vaccines
Market size by End User
Government institutions
Hospitals
NGOs
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dengue Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dengue Vaccine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dengue Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dengue Vaccine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dengue Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dengue Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Dengue Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dengue Vaccine Market Size Growth Rate by Product
1.4.2 CYD-TDV
1.4.3 DENVax or TAK-003
1.4.4 TetraVax-DV
1.4.5 TDENV PIV
1.4.6 V180
1.4.7 DNA vaccines
1.5 Market by End User
1.5.1 Global Dengue Vaccine Market Size Growth Rate by End User
1.5.2 Government institutions
1.5.3 Hospitals
1.5.4 NGOs
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Dengue Vaccine Market Size
2.1.1 Global Dengue Vaccine Revenue 2014-2025
2.1.2 Global Dengue Vaccine Sales 2014-2025
2.2 Dengue Vaccine Growth Rate by Regions
2.2.1 Global Dengue Vaccine Sales by Regions
2.2.2 Global Dengue Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Dengue Vaccine Sales by Manufacturers
3.1.1 Dengue Vaccine Sales by Manufacturers
3.1.2 Dengue Vaccine Sales Market Share by Manufacturers
3.1.3 Global Dengue Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Dengue Vaccine Revenue by Manufacturers
3.2.1 Dengue Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Dengue Vaccine Price by Manufacturers
3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dengue Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Dengue Vaccine Sales by Product
4.2 Global Dengue Vaccine Revenue by Product
4.3 Dengue Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Dengue Vaccine Breakdown Data by End User
6 North America
6.1 North America Dengue Vaccine by Countries
6.1.1 North America Dengue Vaccine Sales by Countries
6.1.2 North America Dengue Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Dengue Vaccine by Product
6.3 North America Dengue Vaccine by End User
7 Europe
7.1 Europe Dengue Vaccine by Countries
7.1.1 Europe Dengue Vaccine Sales by Countries
7.1.2 Europe Dengue Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Dengue Vaccine by Product
7.3 Europe Dengue Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Dengue Vaccine by Countries
8.1.1 Asia Pacific Dengue Vaccine Sales by Countries
8.1.2 Asia Pacific Dengue Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Dengue Vaccine by Product
8.3 Asia Pacific Dengue Vaccine by End User
9 Central & South America
9.1 Central & South America Dengue Vaccine by Countries
9.1.1 Central & South America Dengue Vaccine Sales by Countries
9.1.2 Central & South America Dengue Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Dengue Vaccine by Product
9.3 Central & South America Dengue Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Dengue Vaccine by Countries
10.1.1 Middle East and Africa Dengue Vaccine Sales by Countries
10.1.2 Middle East and Africa Dengue Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Dengue Vaccine by Product
10.3 Middle East and Africa Dengue Vaccine by End User
11 Company Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 Company Business Overview
11.1.3 GlaxoSmithKline Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 GlaxoSmithKline Dengue Vaccine Products Offered
11.1.5 GlaxoSmithKline Recent Development
11.2 Merck Sharp & Dohme
11.2.1 Merck Sharp & Dohme Company Details
11.2.2 Company Business Overview
11.2.3 Merck Sharp & Dohme Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Merck Sharp & Dohme Dengue Vaccine Products Offered
11.2.5 Merck Sharp & Dohme Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Business Overview
11.3.3 Sanofi Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Sanofi Dengue Vaccine Products Offered
11.3.5 Sanofi Recent Development
11.4 Takeda Pharmaceuticals
11.4.1 Takeda Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Takeda Pharmaceuticals Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Takeda Pharmaceuticals Dengue Vaccine Products Offered
11.4.5 Takeda Pharmaceuticals Recent Development
11.5 GeneOne Life Sciences
11.5.1 GeneOne Life Sciences Company Details
11.5.2 Company Business Overview
11.5.3 GeneOne Life Sciences Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 GeneOne Life Sciences Dengue Vaccine Products Offered
11.5.5 GeneOne Life Sciences Recent Development
11.6 Medigen Biologics
11.6.1 Medigen Biologics Company Details
11.6.2 Company Business Overview
11.6.3 Medigen Biologics Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Medigen Biologics Dengue Vaccine Products Offered
11.6.5 Medigen Biologics Recent Development
11.7 Panacea Biotec
11.7.1 Panacea Biotec Company Details
11.7.2 Company Business Overview
11.7.3 Panacea Biotec Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Panacea Biotec Dengue Vaccine Products Offered
11.7.5 Panacea Biotec Recent Development
11.8 Sun Pharmaceutical
11.8.1 Sun Pharmaceutical Company Details
11.8.2 Company Business Overview
11.8.3 Sun Pharmaceutical Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Sun Pharmaceutical Dengue Vaccine Products Offered
11.8.5 Sun Pharmaceutical Recent Development
11.9 U.S NIH
11.9.1 U.S NIH Company Details
11.9.2 Company Business Overview
11.9.3 U.S NIH Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 U.S NIH Dengue Vaccine Products Offered
11.9.5 U.S NIH Recent Development
11.10 Vabiotec
11.10.1 Vabiotec Company Details
11.10.2 Company Business Overview
11.10.3 Vabiotec Dengue Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.10.4 Vabiotec Dengue Vaccine Products Offered
11.10.5 Vabiotec Recent Development
12 Future Forecast
12.1 Dengue Vaccine Market Forecast by Regions
12.1.1 Global Dengue Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Dengue Vaccine Revenue Forecast by Regions 2019-2025
12.2 Dengue Vaccine Market Forecast by Product
12.2.1 Global Dengue Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Dengue Vaccine Revenue Forecast by Product 2019-2025
12.3 Dengue Vaccine Market Forecast by End User
12.4 North America Dengue Vaccine Forecast
12.5 Europe Dengue Vaccine Forecast
12.6 Asia Pacific Dengue Vaccine Forecast
12.7 Central & South America Dengue Vaccine Forecast
12.8 Middle East and Africa Dengue Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Dengue Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Dengue Vaccine Product Picture
Table Dengue Vaccine Market Segments
Table Key Manufacturers Dengue Vaccine Covered
Table Global Dengue Vaccine Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Dengue Vaccine Sales Market Share by Product 2014-2025
Figure CYD-TDV Product Picture
Table Major Manufacturers of CYD-TDV
Figure DENVax or TAK-003 Product Picture
Table Major Manufacturers of DENVax or TAK-003
Figure TetraVax-DV Product Picture
Table Major Manufacturers of TetraVax-DV
Figure TDENV PIV Product Picture
Table Major Manufacturers of TDENV PIV
Figure V180 Product Picture
Table Major Manufacturers of V180
Figure DNA vaccines Product Picture
Table Major Manufacturers of DNA vaccines
Table Global Dengue Vaccine Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Government institutions
Figure Hospitals
Figure NGOs
Figure Dengue Vaccine Report Years Considered
Figure Global Dengue Vaccine Market Size 2014-2025 (Million US$)
Figure Global Dengue Vaccine Sales 2014-2025 (K Units)
Table Global Dengue Vaccine Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Dengue Vaccine Sales by Regions 2014-2019 (K Units)
Table Global Dengue Vaccine Sales Market Share by Regions 2014-2019
Figure Global Dengue Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Dengue Vaccine Sales Market Share by Regions
Table Global Dengue Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Dengue Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Dengue Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Dengue Vaccine Revenue Market Share by Regions
Table Global Dengue Vaccine Sales by Manufacturers (2014-2019) (K Units)
Table Global Dengue Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Dengue Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Dengue Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Dengue Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Dengue Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Dengue Vaccine Price (2014-2019) (USD/Unit)
Table Dengue Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Dengue Vaccine Product Type
Table Date of International Manufacturers Enter into Dengue Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Dengue Vaccine Sales by Product (2014-2019) (K Units)
Table Global Dengue Vaccine Sales Share by Product (2014-2019)
Figure Global Dengue Vaccine Sales Market Share by Product (2014-2019)
Figure Global Dengue Vaccine Sales Market Share by Product in 2018
Table Global Dengue Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Dengue Vaccine Revenue Share by Product (2014-2019)
Figure Global Dengue Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Dengue Vaccine Revenue Market Share by Product in 2018
Table Dengue Vaccine Price by Product 2014-2019 (USD/Unit)
Table Global Dengue Vaccine Sales by End User (2014-2019) (K Units)
Table Global Dengue Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Dengue Vaccine Market Share by End User (2014-2019)
Figure Global Sales Dengue Vaccine Market Share by End User in 2018
Figure North America Dengue Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure North America Dengue Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Dengue Vaccine Sales by Countries (2014-2019) (K Units)
Table North America Dengue Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Dengue Vaccine Sales Market Share by Countries
Table North America Dengue Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Dengue Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Dengue Vaccine Revenue Market Share by Countries
Figure United States Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure United States Dengue Vaccine Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Canada Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Dengue Vaccine Sales by Product (2014-2019) (K Units)
Table North America Dengue Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Dengue Vaccine Market Share by Product
Table North America Dengue Vaccine Sales by End User (2014-2019) (K Units)
Table North America Dengue Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Dengue Vaccine Market Share by End User
Figure Europe Dengue Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Europe Dengue Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Dengue Vaccine Sales by Countries (2014-2019) (K Units)
Table Europe Dengue Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Dengue Vaccine Sales Market Share by Countries
Table Europe Dengue Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Dengue Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Dengue Vaccine Revenue Market Share by Countries
Figure Germany Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Germany Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure France Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure UK Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Italy Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Russia Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Dengue Vaccine Sales by Product (2014-2019) (K Units)
Table Europe Dengue Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Dengue Vaccine Market Share by Product
Table Europe Dengue Vaccine Sales by End User (2014-2019) (K Units)
Table Europe Dengue Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Dengue Vaccine Market Share by End User
Figure Asia Pacific Dengue Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Dengue Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Dengue Vaccine Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Dengue Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Dengue Vaccine Sales Market Share by Countries
Table Asia Pacific Dengue Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Dengue Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Dengue Vaccine Revenue Market Share by Countries
Figure China Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure China Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Japan Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Korea Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure India Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Australia Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Dengue Vaccine Sales by Product (2014-2019) (K Units)
Table Asia Pacific Dengue Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Dengue Vaccine Market Share by Product
Table Asia Pacific Dengue Vaccine Sales by End User (2014-2019) (K Units)
Table Asia Pacific Dengue Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Dengue Vaccine Market Share by End User
Figure Central & South America Dengue Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Dengue Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Dengue Vaccine Sales by Countries (2014-2019) (K Units)
Table Central & South America Dengue Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Dengue Vaccine Sales Market Share by Countries
Table Central & South America Dengue Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Dengue Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Dengue Vaccine Revenue Market Share by Countries
Figure Brazil Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Dengue Vaccine Sales by Product (2014-2019) (K Units)
Table Central & South America Dengue Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Dengue Vaccine Market Share by Product
Table Central & South America Dengue Vaccine Sales by End User (2014-2019) (K Units)
Table Central & South America Dengue Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Dengue Vaccine Market Share by End User
Figure Middle East and Africa Dengue Vaccine Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Dengue Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Dengue Vaccine Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Dengue Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Dengue Vaccine Sales Market Share by Countries
Table Middle East and Africa Dengue Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Dengue Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Dengue Vaccine Revenue Market Share by Countries
Figure GCC Countries Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Dengue Vaccine Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Dengue Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Dengue Vaccine Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Dengue Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Dengue Vaccine Market Share by Product
Table Middle East and Africa Dengue Vaccine Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Dengue Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Dengue Vaccine Market Share by End User
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Merck Sharp & Dohme Company Details
Table Merck Sharp & Dohme Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Merck Sharp & Dohme Recent Development
Table Sanofi Company Details
Table Sanofi Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Takeda Pharmaceuticals Company Details
Table Takeda Pharmaceuticals Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Takeda Pharmaceuticals Recent Development
Table GeneOne Life Sciences Company Details
Table GeneOne Life Sciences Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table GeneOne Life Sciences Recent Development
Table Medigen Biologics Company Details
Table Medigen Biologics Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Medigen Biologics Recent Development
Table Panacea Biotec Company Details
Table Panacea Biotec Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Panacea Biotec Recent Development
Table Sun Pharmaceutical Company Details
Table Sun Pharmaceutical Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Sun Pharmaceutical Recent Development
Table U.S NIH Company Details
Table U.S NIH Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table U.S NIH Recent Development
Table Vabiotec Company Details
Table Vabiotec Dengue Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Vabiotec Recent Development
Table Global Dengue Vaccine Sales Forecast by Regions 2019-2025 (K Units)
Table Global Dengue Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Dengue Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Dengue Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Dengue Vaccine Sales Forecast by Product 2019-2025 (K Units)
Table Global Dengue Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Dengue Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Dengue Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Dengue Vaccine Sales Forecast by End User 2019-2025 (K Units)
Table Global Dengue Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Dengue Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Dengue Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Dengue Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Dengue Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Dengue Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Dengue Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Dengue Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Dengue Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Dengue Vaccine Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Dengue Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Dengue Vaccine Value Chain
Table Dengue Vaccine Customers List
Table Dengue Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
デング熱ウイルス診断検査の世界市場：市場規模・現状・予測 Dengue is a mosquito-borne disease caused by the dengue viruses. It is a vector-borne highly communicable disease. There are four distinct but related virus serotypes all of which can cause dengue fever or the more serious forms of the disease, dengue hemorrhagic fever (DHF) and dengue shock syndrom…- 破傷風ワクチンの世界市場：インサイト・予測 Tetanus vaccine, also known as tetanus toxoid (TT), is an inactive vaccine used to prevent tetanus. During childhood five doses are recommended, with a sixth given during adolescence. Additional doses every 10 years are recommended. After three doses almost everyone is initially immune. In those who…
- 養殖ワクチンの世界市場：市場規模・現状・予測 It is a biological preparation that improves immunity to a particular disease work on aquaculture.In 2018, the global Aquaculture Vaccine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the glob…
- 結核ワクチン治療の世界市場：市場規模・現状・予測 Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …
- 結核ワクチン治療の世界市場：市場規模・現状・予測 Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …